Jamaica leads with legal, GMP-certified psychedelics research
Why it Matters: Mental health conditions affect over 1 billion people globally. Psilocybin is emerging as a promising treatment.
Prof. Thejani Rupika Delgoda and her team are developing a proprietary psilocybin extract in Jamaica’s first legal, GMP-certified lab.
- Producing high-quality psilocybin extracts for clinical research
- Investigating therapeutic potential for psychiatric and inflammatory diseases
- Leveraging Jamaica’s legal framework for global leadership in psychedelic science
